To get an introduction to this sector read below
Company History and Management
Windlas Biotech Ltd, incorporated on February 19, 2001, is a leading pharmaceutical contract development and manufacturing organization (CDMO) in India, headquartered in Dehradun, Uttarakhand. It has grown to become one of the top five players in the Indian CDMO industry, with four state-of-the-art manufacturing facilities and fifth one commenced in 2025
The management team comprises experienced professionals with significant industry expertise:
Hitesh Windlass: Managing Director, leading strategic initiatives.
Manoj Kumar Windlass: Joint Managing Director, overseeing operations.
Komal Gupta: CEO & CFO since 2015, driving financial strategy.
Vivek Dhariwal: Chairman & Independent Director, ensuring governance.
Other key members include Ashok Kumar Windlass (Whole Time Director), Pawan Kumar Sharma (Executive Director), and independent directors Gaurav Gulati and Srinivasan Venkataraman.
Business Model
Windlas Biotech operates primarily as a domestic CDMO, offering services from product discovery to commercial manufacturing of generic products, including complex generics. It also markets its own branded products in trade generics and over-the-counter (OTC) markets and engages in exports.
Revenue breakdown
The company serves marquee clients like Pfizer, Sanofi, and Cadila, focusing on therapeutic categories such as anti-diabetic, cardiovascular, and respiratory therapies.
Windlas Biotech is consistently profitable with decent ROCE
Windlas Biotech maintains stable margins:
Keep reading with a 7-day free trial
Subscribe to Tankrich to keep reading this post and get 7 days of free access to the full post archives.